New research identifies who should be offered testing for coeliac disease
Targeted testing of individuals with a range of signs and symptoms could improve diagnosis of coeliac disease, a new National Institute for Health Research (NIHR) funded study led by the University of Bristol and published in PLOS ONE has found. Signs and symptoms include family history of coeliac disease, dermatitis herpetiformis, anaemia, type 1 diabetes, osteoporosis and chronic liver disease. (Source: University of Bristol news)
Source: University of Bristol news - October 25, 2021 Category: Universities & Medical Training Tags: Health, Research; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School, Institutes, Bristol Population Health Science Institute, Faculty of Health Sciences, Population Health Sciences; Press Release Source Type: news

World ’ s Deadliest Malaria Parasite Dominance in Africa Could Be Over – Experts
A child health consultation at Obunga Dispensary in Homa Bay, one of the eight counties participating in the malaria vaccine pilot program. Credit: Joyce Chimbi/IPSBy Joyce ChimbiNairobi, Kenya, Oct 25 2021 (IPS) One morning in 2016, Lillian Nekesa’s 3-year-old woke up with flu-like classic symptoms of malaria. This was not Kevin’s first encounter with the killer disease. Kevin was nonetheless not immediately rushed to Busia County Referral Hospital for advanced treatment in keeping with his severe symptoms. Nekesa rushed him to a village dispensary because the referral hospital is an hour’s walk away fr...
Source: IPS Inter Press Service - Health - October 25, 2021 Category: International Medicine & Public Health Authors: Joyce Chimbi Tags: Africa COVID-19 Development & Aid Featured Headlines Health Human Rights Inequity TerraViva United Nations ​#Health​ #MalariaVaccine Kenya Source Type: news

What is Refeeding Syndrome?
Discussion Anorexia nervosa is an eating disorder with an intense fear of being overweight (i.e. distorted body image), and self-starvation and excessive weight loss. It is more common in women (1.2%) than men (0.2%) but can be seen in both genders. Risk factors include high-intelligence, perfectionism/inflexibility, anxiety, activities where thinner body types are expected (e.g. dancer, diver, gymnast, long-distance runner, volleyball player, etc.) Other eating disorders include bulimia nervosa (i.e. cycles of binge eating and then purging), binge eating disorder (i.e. purging), orthorexia (i.e. obsessions with healthful ...
Source: PediatricEducation.org - October 25, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Vitamin B12 deficiency: Four behavioural changes which could be warnings signs
VITAMIN B12 or folate deficiency anaemia can cause a wide range of symptoms, according to the NHS. Vitamin B12 deficiency anaemia is a condition in which your body does not have enough healthy red blood cells, due to a lack of vitamin B12. (Source: Daily Express - Health)
Source: Daily Express - Health - October 24, 2021 Category: Consumer Health News Source Type: news

Caring for a Resident With Serious Mental Illness
Mrs. R is an 89-year-old resident with a history of schizophrenia, insulin-dependent diabetes, hypertension, osteoarthritis, osteopenia, vascular dementia, and iron deficiency anemia (underlying cause unknown). She had a hip fracture two years ago and has had a right total hip replacement. She moved into the nursing home after an acute hospital admission for increased confusion and delusional ideation with distorted body image. She believes that her feet and legs are absent and that she cannot walk. (Source: Caring for the Ages)
Source: Caring for the Ages - October 24, 2021 Category: Health Management Authors: Barbara Resnick, Paige Hector Tags: IDT Case Scenario #12 Source Type: news

Red Blood Cells Activate Innate Immune System
Researchers link the ability of the cells to bind and present DNA from pathogens and cell death to anemia, which is common in COVID-19, and immune activation. (Source: The Scientist)
Source: The Scientist - October 21, 2021 Category: Science Tags: News & Opinion Source Type: news

Millions of diabetics could benefit from a new life-saving drug treatment
MILLIONS of diabetics in the UK could benefit from a new drug treatment, originally in clinical trials for a completely different health condition altogether - anaemia. (Source: Daily Express - Health)
Source: Daily Express - Health - October 19, 2021 Category: Consumer Health News Source Type: news

Supplement warning: Three pills that could worsen heart issues, depression and cancer risk
SUPPLEMENTS such as vitamin B12, that can help prevent anaemia, and folic acid, which can reduce birth defects when taken by pregnant women are great additions to a diet. However, some supplements might be risky. (Source: Daily Express - Health)
Source: Daily Express - Health - October 19, 2021 Category: Consumer Health News Source Type: news

Strike in Haiti over crime shuts down country amid search for missionaries
A protest strike shuttered businesses, schools and public transportation in a new blow to Haiti's anemic economy, and unions and other... (Source: Reuters: Health)
Source: Reuters: Health - October 19, 2021 Category: Consumer Health News Source Type: news

What Causes Irritability?
Discussion Child abuse or non-accidental trauma is a clinical diagnosis. It is the constellation of history, physical examination, radiographic evaluation, laboratory testing and investigation that determines if child abuse has occurred. Irritability caused by fractures or other trauma can be a presenting symptom of abuse. Fractures can be a presentation but they are also common problems not associated with abuse. Femoral shaft fractures are estimated to account for only 1.6% of all fractures in children, therefore they are potentially more suspicious for child abuse. A review of femur fractures can be found here. A review...
Source: PediatricEducation.org - October 18, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Janssen Showcases Commitment to Advancing Scientific Innovation in Pulmonary Arterial Hypertension (PAH) at CHEST 2021 Annual Meeting
TITUSVILLE, N.J. – October 14, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today 11* abstracts highlighting data from its pulmonary hypertension (PH) portfolio will be presented at CHEST 2021, the annual meeting of the American College of Chest Physicians, held virtually October 17-20.Data presentations from eight abstracts will provide additional evidence supporting the role of objective multiparameter risk assessment approaches in helping to optimize treatment and care for pulmonary arterial hypertension (PAH), as well as the impact of earlier and comprehensive therapy with ...
Source: Johnson and Johnson - October 14, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Vitamin B12 supplements: Three 'insidious' warning signs of a detrimental deficiency
VITAMIN b12 supplementation might be required to restore fully functioning red blood cells. Without doing so, the impact of megaloblastic anaemia will continue to affect your day-to-day life. (Source: Daily Express - Health)
Source: Daily Express - Health - September 29, 2021 Category: Consumer Health News Source Type: news

The bias that blinds: why some people get dangerously different medical care
Medical research and practice have long assumed a narrow definition of the ‘default’ human, badly compromising the care of anyone outside that category. How can this be fixed?I met Chris in my first month at a small, hard-partying Catholic high school in north-eastern Wisconsin, where kids jammed cigarettes between the fingers of the school ’s lifesize Jesus statue and skipped mass to eat fries at the fast-food joint across the street. Chris and her circle perched somewhere adjacent to the school’s social hierarchy, and she surveyed the adolescent drama and absurdity with cool, heavy-lidded understa...
Source: Guardian Unlimited Science - September 21, 2021 Category: Science Authors: Jessica Nordell Tags: Science Health Doctors Medical research Hospitals Women & wellbeing GPs Race Gender Source Type: news

Vitamin B12 deficiency symptoms: Three problematic signs of 'severe' low B12
A VITAMIN B12 deficiency undoubtedly will lead to anaemia if left undiagnosed and untreated. This is because the nutrient is crucial to form healthy red blood cells, which are needed to transport oxygen around the body. (Source: Daily Express - Health)
Source: Daily Express - Health - September 17, 2021 Category: Consumer Health News Source Type: news

Sickle cell anaemia: Are you at risk of two 'very serious' life-threatening complications?
SICKLE cell disease is an inherited blood disorder where the red blood cells develop abnormally, forming a rigid crescent shape that is unable to supply adequate stores of oxygen around the body. (Source: Daily Express - Health)
Source: Daily Express - Health - September 17, 2021 Category: Consumer Health News Source Type: news

Janssen Presents Results from Phase 1b/2 NORSE Study in Patients with Metastatic or Locally Advanced Urothelial Carcinoma Treated with BALVERSA ® (erdafitinib) in Combination with Cetrelimab, a PD-1 Inhibitor
September 17, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from the Phase 1b/2 NORSE (NCT03473743) study evaluating BALVERSA® (erdafitinib) in combination with cetrelimab, an anti-programmed cell death protein 1 (PD-1) monoclonal antibody, compared to BALVERSA® monotherapy in patients with locally advanced or metastatic urothelial carcinoma (mUC) with fibroblast growth factor receptor (FGFR)3 or FGFR2 genetic alterations who are ineligible for cisplatin, a current standard of care treatment for mUC. The results were highlighted in an oral present...
Source: Johnson and Johnson - September 17, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Drug Might Stop Heart Trouble Linked to Sickle Cell Anemia
Title: Drug Might Stop Heart Trouble Linked to Sickle Cell AnemiaCategory: Health NewsCreated: 9/17/2021 12:00:00 AMLast Editorial Review: 9/17/2021 12:00:00 AM (Source: MedicineNet Chronic Pain General)
Source: MedicineNet Chronic Pain General - September 17, 2021 Category: Anesthesiology Source Type: news

Pioneering Gene Therapy Freed Her of Sickle Cell. Is a Cure at Hand?
Such treatments are extraordinarily promising and costly. Will the Biden administration commit to spending that could speed clinical trial results? (Source: NYT Health)
Source: NYT Health - September 14, 2021 Category: Consumer Health News Authors: Gina Kolata Tags: Sickle Cell Anemia Drugs (Pharmaceuticals) Research Clinical Trials Genetic Engineering Genetics and Heredity Race and Ethnicity Source Type: news

I ’m Haunted by Sisters With Sickle Cell: Two Thrived. Two Suffered.
The cruelty of their unequal outcomes — with one pair freed of disabling symptoms and the other’s suffering unabated — stayed with me. (Source: NYT Health)
Source: NYT Health - September 14, 2021 Category: Consumer Health News Authors: Gina Kolata Tags: Genetics and Heredity Genetic Engineering Boston Children ' s Hospital Immunotherapy Clinical Trials Women and Girls Sickle Cell Anemia Stroke Tests (Medical) Transfusions Source Type: news

What Are the Advantages and Disadvantages of Different Renal Replacement Therapies?
Discussion Kidneys are amazing in that they filter the blood, eliminate toxins, balance fluids and electrolytes plus have a lot of reserve to do the job they need to do even when injured. Therefore, depending on the problem, chronic renal disease (CRD) often allows time before renal replacement therapy (RRT) is needed. RRT currently is dialysis (peritoneal or hemodialysis) or renal transplant. In general, the patient’s own kidneys do the best job for them but there is always a balance between the problems of CRD and its management, versus the potentially improved renal function with RRT. RRT itself though has a diffe...
Source: PediatricEducation.org - September 13, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

ERLEADA ® (apalutamide) Oral Presentations Demonstrate Importance of Prostate Specific Antigen (PSA) as Key Efficacy Indicator and Show Strong Patient Adherence Rates
September 11, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data demonstrating robust prostate-specific antigen (PSA) response and strong adherence rates in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) treated with ERLEADA® (apalutamide) in the real-world clinical setting. The strong PSA response was also seen in a separate post-hoc analysis that showed a correlation between rapid and deep PSA response and prolonged survival in both metastatic castration-sensitive prostate cancer (mCSPC) and nmCRPC. The post-hoc analysis also...
Source: Johnson and Johnson - September 12, 2021 Category: Pharmaceuticals Source Type: news

Mayo Clinic Q & amp;A podcast: Treating birth defects before a baby is born
Birth defects affect 1 in every 33 babies born in the U.S. each year, according to the Centers for Disease Control and Prevention. Before a baby is born, early intervention using fetal surgery can treat life-threatening birth defects and improve outcomes in some cases. Fetal surgeons at Mayo Clinic Children's Center treat many conditions, including: Spina bifida (myelomeningocele).Twin anemia-polycythemia sequence (TAPS).Twin reversed arterial perfusion (TRAP) sequence.Twin-twin transfusion syndrome (TTTS).Lower urinary tract obstruction (LUTO). On the Mayo Clinic Q&A… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 10, 2021 Category: Databases & Libraries Source Type: news

Vitamin B12 deficiency: Three symptoms that can lead to nerve damage - what to look for
VITAMIN B12 deficiency is fairly common in the UK, particularly in older people, affecting around one in 10 people aged 75 or over and one in 20 people aged 65 to 74. Vitamin B12 or folate deficiency anaemia can cause a wide range of symptoms. These usually develop gradually, but can worsen if the condition goes untreated. (Source: Daily Express - Health)
Source: Daily Express - Health - September 9, 2021 Category: Consumer Health News Source Type: news

Iron Deficiency in Pregnancy Is Common, yet Screening Is Lacking Iron Deficiency in Pregnancy Is Common, yet Screening Is Lacking
Many pregnant patients are not being screened for iron deficiency despite it being a common cause of anemia in pregnancy that could increase the risk of maternal and infant death.Medscape Medical News (Source: Medscape Med Students Headlines)
Source: Medscape Med Students Headlines - September 8, 2021 Category: Universities & Medical Training Tags: Ob/Gyn & Women ' s Health News Source Type: news

Janssen Demonstrates Commitment to Advancing Science and Innovation in the Treatment of Solid Tumors at ESMO Annual Congress
September 8, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than ten data presentations from its lung cancer, bladder cancer and prostate cancer portfolio and pipeline will be featured during the European Society for Medical Oncology (ESMO) Annual Congress 2021 virtual meeting, September 16–21. Further details about these data and the science Janssen is advancing will be made available throughout ESMO via the Janssen Oncology Virtual Newsroom.“With a diverse oncology portfolio and pipeline spanning bladder cancer, lung cancer and prostate can...
Source: Johnson and Johnson - September 8, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Consumer Health: Sickle cell disease
Sickle cell disease, which is a group of inherited red blood cell disorders, affects approximately 100,000 people in the U.S., according to the Centers for Disease Control and Prevention. September is National Sickle Cell Awareness Month, which makes this a good time to learn about two of the most common types of sickle cell disease: sickle cell anemia and thalassemia. Sickle cell anemia Sickle cell anemia is caused by a mutation in the gene that… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 8, 2021 Category: Databases & Libraries Source Type: news

Striving to Deliver Better Outcomes: Janssen to Showcase Commitment to Advancing Science for Genitourinary Cancers at AUA 2021
August 31, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today multiple company-sponsored presentations in prostate and bladder cancers will be highlighted at the virtual 2021 American Urological Association Annual Meeting (AUA 2021), September 10-13. “Janssen maintains a strong commitment to advancing innovation and new therapeutic options for patients with genitourinary malignancies. As the treatment of genitourinary cancers becomes more complex, we continue to work with urologists and their teams to improve outcomes for patients across the continuum of disease...
Source: Johnson and Johnson - August 31, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Abbott introduces single-dose formulation of carbetocin in India
PPH, if left untreated, can result in complications like anaemia in the postpartum period or aggravate mental health problems including postnatal depression and post-traumatic stress disorder apart from other issues. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 31, 2021 Category: Pharmaceuticals Source Type: news

Roxadustat Treats Anemia in Non - Dialysis - Dependent CKD
Pooled data show roxadustat versus placebo increases hemoglobin levels with an acceptable profile for cardiovascular safety (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 23, 2021 Category: Cancer & Oncology Tags: Cardiology, Internal Medicine, Nephrology, Oncology, Pharmacy, Journal, Source Type: news

Roxadustat Treats Anemia in Non-Dialysis-Dependent CKD
MONDAY, Aug. 23, 2021 -- For patients with non-dialysis-dependent chronic kidney disease (CKD) and CKD-related anemia, roxadustat increases hemoglobin levels and reduces the need for red blood cell transfusions, according to a study published in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 23, 2021 Category: Pharmaceuticals Source Type: news

After stalling in the U.S., FibroGen anemia drug wins European nod and $120M partner payout
The drug is approved for chronic kidney disease patients in Europe, Japan, China, Chile and South Korea but was rejected earlier this month by U.S. regulators. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 20, 2021 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

After stalling in the U.S., FibroGen anemia drug wins European nod and $120M partner payout
The drug is approved for chronic kidney disease patients in Europe, Japan, China, Chile and South Korea but was rejected earlier this month by U.S. regulators. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 20, 2021 Category: Biotechnology Authors: Ron Leuty Source Type: news

Supplements for anaemia: Differing symptoms of a vitamin B12 or folate deficiency anaemia
SUPPLEMENTS can be taken to top up vitamin B12 stores or folic acid levels; without adequate supply of either nutrient, megaloblastic anaemia can develop - alongside health risks. (Source: Daily Express - Health)
Source: Daily Express - Health - August 18, 2021 Category: Consumer Health News Source Type: news

Preliminary study of coping, perceived control, and depressive symptoms in youth with sickle cell anemia - Prussien KV, Siciliano RE, Ciriegio AE, Lee CA, DeBaun MR, Jordan LC, Compas BE.
OBJECTIVE: The primary objective of this study was to test perceived controllability of stressors as a moderator of the association between coping and depressive symptoms in children and adolescents with sickle cell anemia (SCA). METHOD: Twenty-eig... (Source: SafetyLit)
Source: SafetyLit - August 18, 2021 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

FibroGen tumbles as FDA says new study needed for marquee anemia drug
The road to the first approval in the 27-year-old company's history got rockier, with the FDA saying another costly, time-consuming study would be needed. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 11, 2021 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

FibroGen tumbles as FDA says new study needed for marquee anemia drug
The road to the first approval in the 27-year-old company's history got rockier, with the FDA saying another costly, time-consuming study would be needed. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 11, 2021 Category: Biotechnology Authors: Ron Leuty Source Type: news

FibroGen Receives Complete Response Letter from the FDA for Roxadustat for Anemia of Chronic Kidney Disease
SAN FRANCISCO, Aug. 11, 2021 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the New Drug Application... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - August 11, 2021 Category: Drugs & Pharmacology Source Type: news

Elevated Anemia Risk Even Years After Bariatric Surgery Elevated Anemia Risk Even Years After Bariatric Surgery
People with obesity who undergo bariatric surgery may be more likely to experience anemia years later than counterparts who opt against surgery, a new study suggests.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - August 10, 2021 Category: Surgery Tags: Diabetes & Endocrinology News Source Type: news

Changing Diets Mean More Americans Are Anemic Now
WEDNESDAY, Aug. 4, 2021 -- Growing numbers of Americans aren't getting enough iron in their diets most likely due to changes in farming practices and a shift away from red meat, researchers report. The upshot: Rates of iron-deficiency anemia are on... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 4, 2021 Category: General Medicine Source Type: news

MRNA ’s Next Chapter Has Nothing to Do With COVID-19 Vaccines
It’s safe to say that before the development of the Pfizer-BioNTech and Moderna COVID-19 vaccines, most people hadn’t thought about messenger RNA, or mRNA, since high school science class—if ever. The molecule plays a pivotal role in the body, carrying the recipes for making various proteins to the parts of cells that produce them. But “mRNA” wasn’t exactly a common phrase until Pfizer-BioNTech and Moderna harnessed the genetic material’s power to teach the body to make a piece of a protein found on the COVID-19 virus’ surface, thus training it to fight the real thing, were i...
Source: TIME: Science - August 2, 2021 Category: Science Authors: Jamie Ducharme Tags: Uncategorized healthscienceclimate medicine Source Type: news

MRNA ’s Next Chapter Has Nothing to Do With COVID-19 Vaccines
It’s safe to say that before the development of the Pfizer-BioNTech and Moderna COVID-19 vaccines, most people hadn’t thought about messenger RNA, or mRNA, since high school science class—if ever. The molecule plays a pivotal role in the body, carrying the recipes for making various proteins to the parts of cells that produce them. But “mRNA” wasn’t exactly a common phrase until Pfizer-BioNTech and Moderna harnessed the genetic material’s power to teach the body to make a piece of a protein found on the COVID-19 virus’ surface, thus training it to fight the real thing, were i...
Source: TIME: Health - August 2, 2021 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthscienceclimate medicine Source Type: news

Landmark study finds one in two hospitalised COVID-19 patients develop a complication, NIHR
A large-scale, NIHR-supported observational study published in The Lancet has found that one in two people hospitalised with COVID-19 during the first phase of the pandemic developed at least one health complication as a result of the viral infection. The ISARIC/CO-CIN study is the most comprehensive of its kind - and the first to systematically assess a range of in-hospital complications and their associations with age, sex and ethnicity - and their outcomes for the patients. The researchers assessed more than 70,000 hospitalised adult patients in the UK hospitalised with severe COVID-19 disease between January and Augu...
Source: Current Awareness Service for Health (CASH) - July 26, 2021 Category: Consumer Health News Source Type: news

FDA grants Breakthrough Therapy Designation for Venclexta in combination with azacitidine for the treatment of patients with myelodysplastic syndromes
Basel, 21 July 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that Venclexta ® (venetoclax) in combination with azacitidine has been granted Breakthrough Therapy Designation (BTD) by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with previously untreated intermediate, high- and very high-risk myelodysplastic syndromes (MDS) based on the rev ised International Prognostic Scoring System (IPSS-R). MDS are a rare group of blood cancers that gradually affect the ability of the bone marrow to produce normal blood cells.2 This can lead to weakness, frequent infections, anaemia and ...
Source: Roche Media News - July 21, 2021 Category: Pharmaceuticals Source Type: news

FDA grants Breakthrough Therapy Designation for Venclexta in combination with azacitidine for the treatment of patients with myelodysplastic syndromes
Basel, 21 July 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that Venclexta ® (venetoclax) in combination with azacitidine has been granted Breakthrough Therapy Designation (BTD) by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with previously untreated intermediate, high- and very high-risk myelodysplastic syndromes (MDS) based on the rev ised International Prognostic Scoring System (IPSS-R). MDS are a rare group of blood cancers that gradually affect the ability of the bone marrow to produce normal blood cells.2 This can lead to weakness, frequent infections, anaemia and ...
Source: Roche Investor Update - July 21, 2021 Category: Pharmaceuticals Source Type: news

What Happens to a Person with Sickle Cell Anemia
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - July 20, 2021 Category: General Medicine Source Type: news

Vitamin B12 deficiency: Toiletry troubles indicative of long-term deficiency
A VITAMIN B12 deficiency can escalate to anaemia - a lack of healthy red blood cells, which means that less oxygen is delivered to vital organs. As time goes on, symptoms will begin to emerge. (Source: Daily Express - Health)
Source: Daily Express - Health - July 18, 2021 Category: Consumer Health News Source Type: news

Sandoz launches first generic high dose intravenous iron, Ferumoxytol Injection, to treat US patients with iron deficiency anemia
Patients with iron deficiency anemia in a hospital or clinic setting now have access to an important IV iron medicine at a more affordable price Iron deficiency anemia occurs when there is a lower than normal number of oxygen-carrying red blood cells be... Biopharmaceuticals, Generics, Product Launch Sandoz, Novartis, Ferumoxytol, iron deficiency (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 16, 2021 Category: Pharmaceuticals Source Type: news

FDA Panel Rejects Roxadustat for Anemia in Kidney Disease FDA Panel Rejects Roxadustat for Anemia in Kidney Disease
An FDA advisory committee voted by 1-13 and 2-12 margins against approving a novel, oral agent, roxadustat, for treating anemia in patients with chronic kidney disease. Safety was the major issue.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 16, 2021 Category: Consumer Health News Tags: Nephrology News Source Type: news

Status on FDA Advisory Committee Vote on Roxadustat in Anemia of Chronic Kidney Disease
16 July 2021 -- The Food and Drug Administration’s (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) has voted 13 to 1 that the benefit-risk profile of roxadustat does not support approval for the treatment of anemia in chronic... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - July 16, 2021 Category: Drugs & Pharmacology Source Type: news

Iron Deficiency May Increase Mortality, CV Risks in Nondialysis CKD
WEDNESDAY, July 14, 2021 -- For patients with nondialysis chronic kidney disease (CKD), with or without anemia, iron deficiency as reflected by a serum biomarker of iron stores is associated with an increased risk for all-cause mortality and major... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 14, 2021 Category: Pharmaceuticals Source Type: news